Procter & Gamble Health Care — Net Sales increased by 5.8% to $3.41B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.8%, from $3.25B to $3.41B. Over 4 years (FY 2021 to FY 2025), Health Care — Net Sales shows an upward trend with a 4.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase reflects growing market share or successful product adoption, while a decrease suggests weakening demand or competitive pressure.
This represents the total revenue generated by the Health Care segment after deducting returns, allowances, and discount...
Commonly reported as 'Segment Revenue' in peer financial disclosures.
pg_segment_health_care_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.30B | $2.68B | $2.98B | $2.66B | $3.15B | $2.76B | $3.05B | $2.83B | $3.42B | $3.07B | $3.17B | $2.87B | $3.52B | $3.15B | $3.25B | $2.88B | $3.75B | $3.22B | $3.41B |
| QoQ Change | — | -18.8% | +11.2% | -10.6% | +18.2% | -12.4% | +10.7% | -7.3% | +20.8% | -10.0% | +3.2% | -9.4% | +22.7% | -10.7% | +3.2% | -11.4% | +30.1% | -14.0% | +5.8% |
| YoY Change | — | — | — | — | -4.6% | +3.0% | +2.5% | +6.2% | +8.6% | +11.5% | +4.0% | +1.6% | +3.1% | +2.4% | +2.4% | +0.2% | +6.3% | +2.3% | +4.8% |
We use cookies for analytics. See our Privacy and Cookie Policy.